Financials
- Market Capitalization 452.96 M
- Employee 485
- Founded 2008
- CEO Jason Kelly
- Website www.ginkgobioworks.com
- Headquarter Delaware, United States
- FIGI BBG00YPS1KY3
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.98
売上高対価格比率
4.57
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2985 | GALT Galectin Therapeutics Inc. - Common Stock | 4.50 USD | +7.91% | +8.43% | +51.52% | +1.35% | 453.82 M USD | ||
| 2986 | OCGN Ocugen, Inc. - Common Stock | 1.33 USD | 0.00% | -5.67% | +7.26% | +31.68% | 451.02 M USD | ||
| 3006 | PRLD Prelude Therapeutics Incorporated - Common Stock | 5.44 USD | -0.91% | -17.07% | +16.99% | +385.71% | 434.13 M USD | ||
| 3007 | BNTC Benitec Biopharma Inc. - Common Stock | 12.88 USD | +4.63% | 0.00% | +8.51% | -22.46% | 442.48 M USD |